
Zhejiang Benli Technology Co.,ltd.
浙江本立科技
Zhejiang Benli Technology Co.,ltd.
Biotech/Healthcare
Benli Technology develops and sells pharmaceutical intermediates, primarily quinolone drug intermediates. Its products include ethyl N,N-dimethylaminomethylene acrylate and ethyl 3-(cyclopropylamino)-2-(2,4-dichloro-5-fluorobenzoyl)acrylate, and are sold in markets including India and Japan.
Latest round: Post-IPO (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-03-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.